Skip to content
Review

Past achievements and future perspectives of personalized vaccines and the role of dendritic cells

Aug 2026 · Immunologic research · Vol 74 · 0 citations · 116 references
Medicine

TL;DR

How convergence of immunology, computational biology, and advanced vaccine technologies could expand the scope of personalized vaccination, from oncology to future epidemic and pandemic scenarios as well as the current challenges is highlighted.

View source

Similar papers

Review Open access Jul 2026

The promising cancer treatment approach in cancer immunotherapy: dendritic cell-based vaccines

Dendritic cells (DCs), as the most protent professional antigen-presenting cells (APCs), possess an exceptional capacity to initiate and modulate adaptive immune responses, rendering DC-based vaccines a highly promising approach in tumor immunotherapy. This review explores the biological properties of DCs, establishing...

Jingwen Wang, Xi-Biao Jia, Yaxin Zhang et al. · 0 citations
Review Open access Sep 2026

Therapeutic melanoma vaccines: Platforms, neoantigen strategies, and emerging combination immunotherapies

Melanoma has emerged as a major focus of cancer immunotherapy research because of its highly immunogenic nature and responsiveness to immune-based treatments. Therapeutic melanoma vaccines are designed to stimulate tumor-specific immune responses through the delivery of Tumor-Associated Antigens (TAAs), Tumor-Specific...

D. Mhanna, Bilal Salman, Rawad El Hakim et al. · 0 citations
Review Open access Aug 2026

Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy

It is proposed that the future maturation of PCVs will require a coordinated process across five interconnected dimensions: advances in neoantigen prediction technologies, rapid delivery of PCVs to patients, an increase in anticancer efficacy through combination therapy strategies, establishment of cost-effective manuf...

Seongje Cho, Jisun Lee, Young-Min Lee et al. · 0 citations
Review Sep 2026

Cancer vaccines as targeted therapies: translational advances and challenges.

Cancer vaccines represent a promising class of immunotherapeutic agents with potential applications in cancer prevention and treatment. By eliciting tumor-specific immune responses, these vaccines may offer durable protection against tumor progression, recurrence, and metastasis while minimizing off-target toxicity ass...

Zahra Shafaghat, Maryam Sadri, Mona Roozbehani et al. · 0 citations
Review Sep 2026

Therapeutic Cancer Vaccines: Classification, Mechanisms, Challenges and Future Perspectives.

BACKGROUND With the rapid advancements in oncology, immunology, and molecular biology, immunotherapy has emerged as a cornerstone of anti-tumor treatment, complementing traditional modalities such as surgery, radiotherapy, and chemotherapy. Therapeutic cancer vaccines are a promising immunotherapy strategy that deliver...

Ju-Wei Gao, Yue Sun, Zi-Jing Han et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.